Faisal Farooq

Faisal Farooq

Auto-generated profile, based on publicly available information

Faisal Farooq

Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
RARawan AlSaad
Rawan AlSaad
SASarah Aziz
Sarah Aziz
AAArfan Ahmed
Arfan Ahmed
KDKerstin Denecke
Kerstin Denecke
JSJavaid Sheikh
Javaid Sheikh
Background: Anxiety and depression are the most common mental disorders worldwide. Owing to the lack of psychiatrists around the world, the incorporation of artificial intelligence (AI) into wearable devices (wearable AI) has been exploited to provide mental health services. Objective: This review aimed to explore the features of wearable AI used for anxiety and depression to identify application areas and open research issues. Methods: We searched 8 electronic databases (MEDLINE, PsycINFO, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar) and included studies that met the inclusion criteria. Then, we checked the studies that cited the included studies and screened studies that were cited by the included studies. The study selection and data extraction were carried out by 2 reviewers independently. The extracted data were aggregated and summarized using narrative synthesis. Results: Of the 1203 studies identified, 69 (5.74%) were included in this review. Approximately, two-thirds of the studies used wearable AI for depression, whereas the remaining studies used it for anxiety. The most frequent application of wearable AI was in diagnosing anxiety and depression; however, none of the studies used it for treatment purposes. Most studies targeted individuals aged between 18 and 65 years. The most common wearable device used in the studies was Actiwatch AW4 (Cambridge Neurotechnology Ltd). Wrist-worn devices were the most common type of wearable device in the studies. The most commonly used category of data for model development was physical activity data, followed by sleep data and heart rate data. The most frequently used data set from open sources was Depresjon. The most commonly used algorithm was random forest, followed by support vector machine. Conclusions: Wearable AI can offer great promise in providing mental health services related to anxiety and depression. Wearable AI can be used by individuals for the prescreening assessment of anxiety and depression. Further reviews are needed to statistically synthesize the studies’ results related to the performance and effectiveness of wearable AI. Given its potential, technology companies should invest more in wearable AI for the treatment of anxiety and depression.

9 August 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AAArfan Ahmed
Arfan Ahmed
SASarah Aziz
Sarah Aziz
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
FFFaisal Farooq
Faisal Farooq
JSJavaid Sheikh
Javaid Sheikh
Background: Prevalence of diabetes has steadily increased over the last few decades with 1.5 million deaths reported in 2012 alone. Traditionally, analyzing patients with diabetes has remained a largely invasive approach. Wearable devices (WDs) make use of sensors historically reserved for hospital settings. WDs coupled with artificial intelligence (AI) algorithms show promise to help understand and conclude meaningful information from the gathered data and provide advanced and clinically meaningful analytics. Objective: This review aimed to provide an overview of AI-driven WD features for diabetes and their use in monitoring diabetes-related parameters. Methods: We searched 7 of the most popular bibliographic databases using 3 groups of search terms related to diabetes, WDs, and AI. A 2-stage process was followed for study selection: reading abstracts and titles followed by full-text screening. Two reviewers independently performed study selection and data extraction, and disagreements were resolved by consensus. A narrative approach was used to synthesize the data. Results: From an initial 3872 studies, we report the features from 37 studies post filtering according to our predefined inclusion criteria. Most of the studies targeted type 1 diabetes, type 2 diabetes, or both (21/37, 57%). Many studies (15/37, 41%) reported blood glucose as their main measurement. More than half of the studies (21/37, 57%) had the aim of estimation and prediction of glucose or glucose level monitoring. Over half of the reviewed studies looked at wrist-worn devices. Only 41% of the study devices were commercially available. We observed the use of multiple sensors with photoplethysmography sensors being most prevalent in 32% (12/37) of studies. Studies reported and compared >1 machine learning (ML) model with high levels of accuracy. Support vector machine was the most reported (13/37, 35%), followed by random forest (12/37, 32%). Conclusions: This review is the most extensive work, to date, summarizing WDs that use ML for people with diabetes, and provides research direction to those wanting to further contribute to this emerging field. Given the advancements in WD technologies replacing the need for invasive hospital setting devices, we see great advancement potential in this domain. Further work is needed to validate the ML approaches on clinical data from WDs and provide meaningful analytics that could serve as data gathering, monitoring, prediction, classification, and recommendation devices in the context of diabetes.

14 March 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AAArfan Ahmed
Arfan Ahmed
SASarah Aziz
Sarah Aziz
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
FFFaisal Farooq
Faisal Farooq
MHMowafa Househ
Mowafa Househ
JSJavaid Sheikh
Javaid Sheikh
Background: In 2021 alone, diabetes mellitus, a metabolic disorder primarily characterized by abnormally high blood glucose (BG) levels, affected 537 million people globally, and over 6 million deaths were reported. The use of noninvasive technologies, such as wearable devices (WDs), to regulate and monitor BG in people with diabetes is a relatively new concept and yet in its infancy. Noninvasive WDs coupled with machine learning (ML) techniques have the potential to understand and conclude meaningful information from the gathered data and provide clinically meaningful advanced analytics for the purpose of forecasting or prediction. Objective: The purpose of this study is to provide a systematic review complete with a quality assessment looking at diabetes effectiveness of using artificial intelligence (AI) in WDs for forecasting or predicting BG levels. Methods: We searched 7 of the most popular bibliographic databases. Two reviewers performed study selection and data extraction independently before cross-checking the extracted data. A narrative approach was used to synthesize the data. Quality assessment was performed using an adapted version of the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Results: From the initial 3872 studies, the features from 12 studies were reported after filtering according to our predefined inclusion criteria. The reference standard in all studies overall (n=11, 92%) was classified as low, as all ground truths were easily replicable. Since the data input to AI technology was highly standardized and there was no effect of flow or time frame on the final output, both factors were categorized in a low-risk group (n=11, 92%). It was observed that classical ML approaches were deployed by half of the studies, the most popular being ensemble-boosted trees (random forest). The most common evaluation metric used was Clarke grid error (n=7, 58%), followed by root mean square error (n=5, 42%). The wide usage of photoplethysmogram and near-infrared sensors was observed on wrist-worn devices. Conclusions: This review has provided the most extensive work to date summarizing WDs that use ML for diabetic-related BG level forecasting or prediction. Although current studies are few, this study suggests that the general quality of the studies was considered high, as revealed by the QUADAS-2 assessment tool. Further validation is needed for commercially available devices, but we envisage that WDs in general have the potential to remove the need for invasive devices completely for glucose monitoring in the not-too-distant future. Trial Registration: PROSPERO CRD42022303175; https://tinyurl.com/3n9jaayc

12 December 2025 in JMIR Formative Research
Verified
Journal Article
Open access
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
BSBarry Solaiman
Barry Solaiman
YMYosra Magdi Mekki
Yosra Magdi Mekki
DTDena Al Thani
Dena Al Thani
FFFaisal Farooq
Faisal Farooq
AAArfan Ahmed
Arfan Ahmed
Artificial intelligence (AI) has the capacity to transform health care by improving clinical decision-making, optimizing workflows, and enhancing patient outcomes. However, this potential remains limited by a complex set of technological, human, and ethical barriers that constrain its safe and equitable implementation. This paper argues for a holistic, systems-based approach to AI integration that addresses these challenges as interconnected rather than isolated. It identifies key technological barriers, including limited explainability, algorithmic bias, integration and interoperability issues, lack of generalizability, and difficulties in validation. Human factors such as resistance to change, insufficient stakeholder engagement, and education and resource constraints further impede adoption, whereas ethical and legal challenges related to liability, privacy, informed consent, and inequity compound these obstacles. Addressing these issues requires transparent model design, diverse datasets, participatory development, and adaptive governance. Recommendations emerging from this synthesis are as follows: (1) establish standardized international regulatory and governance frameworks; (2) promote multidisciplinary co-design involving clinicians, developers, and patients; (3) invest in clinician education, AI literacy, and continuous training; (4) ensure equitable resource allocation through dedicated funding and public-private partnerships; (5) prioritize multimodal, explainable, and ethically aligned AI development; and (6) focus on long-term evaluation of AI in real-world settings to ensure adaptive, transparent, and inclusive deployment. Adopting these measures can align innovation with accountability, enabling health care systems to harness AI’s transformative potential responsibly and sustainably to advance patient care and health equity.

Verified
Journal Article
Open access
PDF file
FMFayaz Ahmad Mir
Fayaz Ahmad Mir
EUEhsan Ullah
Ehsan Ullah
Raghvendra MallRaghvendra Mall
Raghvendra Mall
AIAhmad Iskandaranj
Ahmad Iskandaranj
TSTareq A. Samra
Tareq A. Samra
AAAbdul Badi Abou-Samra
Abdul Badi Abou-Samra
Background: Obesity coexists with variable features of metabolic syndrome, which is associated with dysregulated metabolic pathways. We assessed potential associations between serum metabolites and features of metabolic syndrome in Arabic subjects with obesity. Methods: We analyzed a dataset of 39 subjects with obesity only (OBO, n = 18) age-matched to subjects with obesity and metabolic syndrome (OBM, n = 21). We measured 1069 serum metabolites and correlated them to clinical features. Results: A total of 83 metabolites, mostly lipids, were significantly different (p < 0.05) between the two groups. Among lipids, 22 sphingomyelins were decreased in OBM compared to OBO. Among non-lipids, quinolinate, kynurenine, and tryptophan were also decreased in OBM compared to OBO. Sphingomyelin is negatively correlated with glucose, HbA1C, insulin, and triglycerides but positively correlated with HDL, LDL, and cholesterol. Differentially enriched pathways include lysine degradation, amino sugar and nucleotide sugar metabolism, arginine and proline metabolism, fructose and mannose metabolism, and galactose metabolism. Conclusions: Metabolites and pathways associated with chronic inflammation are differentially expressed in subjects with obesity and metabolic syndrome compared to subjects with obesity but without the clinical features of metabolic syndrome.

30 December 2022 in Sustainability
Verified
Journal Article
Open access
PDF file
AAArfan Ahmed
Arfan Ahmed
SASarah Aziz
Sarah Aziz
UQUvais Qidwai
Uvais Qidwai
FFFaisal Farooq
Faisal Farooq
JSJingxuan Shan
Jingxuan Shan
JSJavaid Sheikh
Javaid Sheikh
Eighty one percent of adolescents aged 11–17 years are inadequately physically active worldwide. Physical activity (PA) recommendations for high school children have not been studied previously in schools in the Qatar region. The objectives of the study were: (i) to assess the level of compliance of the recommended PA and to assess if there are any gender differences; and (ii) to analyze the recommended step count compliance during school and non-school days. An observational cross-sectional study was conducted. Twenty-nine children (12 boys and 17 girls) aged 13–17 years (15.24 ± 1.46) took part in this study. Participants wore Fitbit Charge 5 wrist bands for three weeks to collect various digital biomarkers including moderate-to-vigorous physical activity (MVPA) and step counts (tracking during out-of-school time and school time). Based on this study, high school children in the two Qatar region schools did not meet the MVPA and steps/day recommendation by the established agencies: 38% of the total study group met the recommended 60 min/day of activity (50% boys, 29% girls). Gender differences were also observed in PA levels and steps per day: for non-school days, 17% met the recommended 10,000 steps/day (25% boys, 12% girls). There was a pattern of greater PA performance and steps during the weekdays as opposed to the weekend, but these values showed no robust evidence in favor of H1 or statistical significance for step counts. However, the evidence was robust in favor of H1 (difference between weekend and weekday) due to a statistically significant difference for meeting the 60 min/day activity. While further studies are required to establish if this is a general trend in Qatari schools, this pilot study does highlight the need to design more effective programs and messaging strategies to improve PA levels in the high school population.